Clinical trial

Dietary Supplements for the Treatment of Angelman Syndrome

NCT00348933 · University of California, San Diego, Other · Completed

Key facts

NCT number NCT00348933
Title Dietary Supplements for the Treatment of Angelman Syndrome
Official title Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome
Lead sponsor University of California, San Diego, Other
Collaborators Baylor College of Medicine Rady Children's Hospital, San Diego Boston Children's Hospital Greenwood Genetic Center Rare Diseases Clinical Research Network
Status Completed
Study type Interventional
Conditions Angelman Syndrome, Nervous System Diseases
Intervention type Drug
Interventions Betaine, Creatine, Metafolin, Vitamin B12
Enrollment 90
Start date Jul 1, 2006
Primary completion Feb 1, 2010
Completion Feb 1, 2010
First posted Jul 6, 2006
Last update posted Sep 24, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies